Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Neoadjuvant Chemotherapy With Docetaxel After Doxorubicin Plus Cyclophosphamide in Locally Advanced Breast Cancer
NCT01660542Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Apr 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of docetaxel in breast cancer, sponsored by Yonsei University. Primary endpoint: Pathologic Complete Response at 26 weeks. Started Apr 2011; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01660542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660542.